Modis Therapeutics is Biotechnology in United States that focus on inherited mitochondrial disease business. Founded in 2016. They cover business area such as operator, disease-modify therapy, rare genetic disease, clinical development, thymidine, an inherit mitochondrial disease, medical professional, nucleotide balance, mtdna copy number, cell function, life.
2016
( 8 years old in 2024 )
Inherited Mitochondrial Disease
-
409 13th Street
Suite 700
Oakland, CA 94612
United States
Private
operatordisease-modify therapyrare genetic diseaseclinical developmentthymidinean inherit mitochondrial diseasemedical professionalnucleotide balancemtdna copy numbercell functionlife
* We use standard office opening hours in near Modis Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Modis Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Modis Therapeutics business is focusing on Inherited Mitochondrial Disease.
Modis Therapeutics headquarter office and corporate office address is located in 409 13th Street Suite 700 Oakland, CA 94612 United States.
Modis Therapeutics was founded in United States.
In 2024, Modis Therapeutics is currently focus on inherited mitochondrial disease sector.
Above is snippet of Google Trends for "inherited mitochondrial disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Modis Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
